KnowraGLP-1 receptor agonistLinked fromLinked fromThe 11 pages that link to GLP-1 receptor agonist, each with the reason it gives.All 11Broader topic 5Related 2Narrower topic 1Compared with 3Type 2 diabetesBroader topic: These medicines can address glucose levels and weight, with cardiovascular benefits for some agents.MetforminCompared with: These medicines can promote weight loss, whereas metformin’s effects on weight are generally more modest.Insulin therapyCompared with: These medicines can lower glucose through several actions without acting as replacement insulin.Gastric emptyingRelated: This drug class can slow gastric emptying, especially early in treatment.PeptideBroader topic: Several medicines in this class are peptide-based treatments for diabetes and obesity.Subcutaneous injectionBroader topic: Several medicines in this class are administered by subcutaneous injection.Glucagon-like peptide-1Broader topic: These drugs extend GLP-1 signaling beyond the brief action of the natural hormone.Gila monsterNarrower topic: Exendin-4’s medical value comes from its action on this receptor.SitagliptinCompared with: Unlike sitagliptin, these drugs directly activate the receptor and often produce greater weight loss.Non-alcoholic fatty liver diseaseRelated: These medicines can address obesity or diabetes that frequently coexist with fatty liver disease.Diabetes medicationBroader topic: Its effects on appetite, digestion, and insulin link glucose control with weight management.